Medication adherence and long-term functional outcomes in the treatment of Schizophrenia in usual care

Journal of Clinical Psychiatry

Volumn 67, Issue 3, 2006, Pages 453-460

  Ascher Svanum, Haya ^a   Faries, Douglas E ^a   Zhu, Baojin ^a   Ernst, Frank R ^a   Swartz, Marvin S ^b   Swanson, Jeff W ^b  

^a ELI LILLY AND COMPANY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; CRIMINAL JUSTICE; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SUBSTANCE ABUSE; TREATMENT OUTCOME; UNITED STATES; VIOLENCE;

EID: 33645793568     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0317     Document Type: Article

References (31)

1. World Health Organization. Adherence to Long-Term Therapies. Evidence for Action. Geneva, Switzerland: World Health Organization; 2003
2. Sullivan G, Wells KB, Morgenstern H, et al. Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. Am J Psychiatry 1995;152:1749-1756
3. Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001;52:805-811
4. Valenstein M, Copeland LA, Blow FC, et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002;40:630-639
5. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995;21:419-429
6. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Schizophrenia. Am J Psychiatry 1997;154(suppl 4):1-63
7. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909
8. Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004;161:692-699
9. Haywood TW, Kravitz HM, Grossman LS, et al. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 1995;152:856-861
10. Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 2002;54:253-264
11. Salkever DS, Slade EP, Karakus MC, et al. Estimation of antipsychotic effects on hospitalization risk in a naturalistic study with selection on unobservables. J Nerv Ment Dis 2004;192:119-128
12. Swanson JW, Swartz MS, Elbogen E. Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Schizophr Bull 2004;30:3-20
13. Velligan DI, Prihoda TJ, Sui D, et al. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 2003;64:524-531
14. Ascher-Svanum H, Zhu B, Fanes D, et al. A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia. Ann Gen Hosp Psychiatry 2004;3:11
15. Johnsrud M, Schafenmeyer K. Measuring adherence and persistence in drug therapy. J Manag Care Pharm 2002;8:204-205
16. Tafesse E, Hines PL, Carson WH. Atypical antipsychotic adherence and hospitalization in patients with schizophrenia [abstract]. Schizophr Res 2003;60(suppl 1):119
17. Weiden PJ, Kozma C, Grogg A, et al. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004;55:886-891
18. Lehman AF, Fischer EP, Postrado L. The Schizophrenia Care and Assessment Program Health Questionnaire (SCAP-HQ): an instrument to assess outcomes of schizophrenia care. Schizophr Bull 2003;29:247-256
19. Lehman A. A quality of life interview for the chronically mentally ill. Eval Program Plann 1988;11:51-62
20. Cuffel BJ, Fischer EP, Owen RR Jr, et al. An instrument for measurement of outcomes of care for schizophrenia: issues in development and implementation. Eval Health Prof 1997;20:96-108
21. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233
22. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974;131: 1121-1123
23. Mallinckrodt CH, Sanger TM, Dube S, et al. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry 2003;53:754-760
24. Liang KY, Zeger SL. Longitudinal data analyses using generalized linear models. Biometrika 1986;73:13-22
25. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:383-386
26. Swartz MS, Swanson JW, Hiday VA, et al. Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Soc Psychiatry Psychiatr Epidemiol 1998;33(suppl 1):S75-S80
27. Swanson JW, Swartz MS, Elbogen EB, et al. Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. J Clin Psychiatry 2004;65:1666-1673
28. Munetz MR, Grande TP, Chambers MR. The incarceration of individuals with severe mental disorders. Community Ment Health J 2001;37:361-372
29. Kane JM, Leucht S, Carpenter D, et al. Expert Consensus Guideline Series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry 2003;64(suppl 12):5-19
30. Nose M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? a systematic review. Psychol Med 2003;33:1149-1160
31. Lafayette JM, Frankle WG, Pollock A, et al. Clinical characteristics, cognitive functioning, and criminal histories of outpatients with schizophrenia. Psychiatr Serv 2003;54:1635-1640